New Eczema Drug Promising in Early Trial

THURSDAY, March 2, 2017 — An experimental drug may significantly reduce the itching and improve the appearance of moderate to severe eczema, a new, preliminary trial finds.
Nemolizumab is a man-made, injectable antibody that acts against the…
Source: Topamax